IL161972A0 - Coated particulate cefuroxime axetil compositions - Google Patents

Coated particulate cefuroxime axetil compositions

Info

Publication number: IL161972A0
Authority: IL; Israel
Prior art keywords: cefuroxime axetil; coated particulate; compositions; particulate cefuroxime; axetil compositions
Prior art date: 2001-11-23

Application number

IL16197202A

Other languages

English (en)

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-11-23

Filing date

2002-11-21

Publication date

2005-11-20

2002-11-21 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

2005-11-20 Publication of IL161972A0 publication Critical patent/IL161972A0/xx

Links

KEJCWVGMRLCZQQ-YJBYXUATSA-N Cefuroxime axetil Chemical compound N([C@@H]1C(N2C(=C(COC(N)=O)CS[C@@H]21)C(=O)OC(C)OC(C)=O)=O)C(=O)\C(=N/OC)C1=CC=CO1 KEJCWVGMRLCZQQ-YJBYXUATSA-N 0.000 title abstract 2
229960002620 cefuroxime axetil Drugs 0.000 title abstract 2
239000000203 mixture Substances 0.000 title abstract 2
239000007900 aqueous suspension Substances 0.000 abstract 1
239000011230 binding agent Substances 0.000 abstract 1
235000019658 bitter taste Nutrition 0.000 abstract 1
239000000969 carrier Substances 0.000 abstract 1
239000011248 coating agent Substances 0.000 abstract 1
238000000576 coating method Methods 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
239000012530 fluid Substances 0.000 abstract 1
235000003599 food sweetener Nutrition 0.000 abstract 1
230000002496 gastric effect Effects 0.000 abstract 1
239000008187 granular material Substances 0.000 abstract 1
150000002632 lipids Chemical class 0.000 abstract 1
239000003607 modifier Substances 0.000 abstract 1
239000002245 particle Substances 0.000 abstract 1
239000000546 pharmaceutical excipient Substances 0.000 abstract 1
239000003765 sweetening agent Substances 0.000 abstract 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
- A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Oil, Petroleum & Natural Gas (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Biophysics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Glanulating (AREA)

IL16197202A 2001-11-23 2002-11-21 Coated particulate cefuroxime axetil compositions IL161972A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP01500277		2001-11-23
PCT/EP2002/013150 WO2003043638A1 (fr)	2001-11-23	2002-11-21	Compositions de cefuroxime axetil particulaire enrobe

Publications (1)

Publication Number	Publication Date
IL161972A0 true IL161972A0 (en)	2005-11-20

Family

ID=8183502

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
IL16197202A IL161972A0 (en)	2001-11-23	2002-11-21	Coated particulate cefuroxime axetil compositions
IL161972A IL161972A (en)	2001-11-23	2004-05-13	Coated particulate cefuroxime axetil compositions

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
IL161972A IL161972A (en)	2001-11-23	2004-05-13	Coated particulate cefuroxime axetil compositions

Country Status (34)

Country	Link
US (1)	US20030161888A1 (fr)
EP (1)	EP1446126B1 (fr)
JP (1)	JP3497503B2 (fr)
KR (1)	KR100979328B1 (fr)
CN (1)	CN1297274C (fr)
AT (1)	ATE473006T1 (fr)
AU (2)	AU2002338950A1 (fr)
BE (2)	BE1015217A5 (fr)
BR (1)	BR0204767A (fr)
CA (1)	CA2408198C (fr)
CH (1)	CH693982A5 (fr)
CO (1)	CO5580783A2 (fr)
CY (1)	CY1110778T1 (fr)
CZ (1)	CZ12993U1 (fr)
DE (3)	DE60236952D1 (fr)
DK (1)	DK1446126T3 (fr)
ES (2)	ES2201932B2 (fr)
FR (1)	FR2832635B1 (fr)
GB (1)	GB2383536B (fr)
GR (1)	GR1004522B (fr)
HR (2)	HRP20020924A2 (fr)
HU (1)	HUP0204026A3 (fr)
IL (2)	IL161972A0 (fr)
IT (1)	ITMI20022470A1 (fr)
MX (1)	MXPA02011561A (fr)
NO (1)	NO335273B1 (fr)
NZ (1)	NZ533092A (fr)
PL (1)	PL205325B1 (fr)
PT (1)	PT1446126E (fr)
RU (1)	RU2241460C2 (fr)
SI (1)	SI1446126T1 (fr)
TR (1)	TR200202559A2 (fr)
WO (1)	WO2003043638A1 (fr)
ZA (1)	ZA200209473B (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8071128B2 (en) *	1996-06-14	2011-12-06	Kyowa Hakko Kirin Co., Ltd.	Intrabuccally rapidly disintegrating tablet and a production method of the tablets
US9358214B2 (en)	2001-10-04	2016-06-07	Adare Pharmaceuticals, Inc.	Timed, sustained release systems for propranolol
US8367111B2 (en)	2002-12-31	2013-02-05	Aptalis Pharmatech, Inc.	Extended release dosage forms of propranolol hydrochloride
ATE516019T1 (de)	2004-05-11	2011-07-15	Egalet Ltd	Quellbare dosierform mit gellan-gummit
US8747895B2 (en)	2004-09-13	2014-06-10	Aptalis Pharmatech, Inc.	Orally disintegrating tablets of atomoxetine
US9884014B2 (en)	2004-10-12	2018-02-06	Adare Pharmaceuticals, Inc.	Taste-masked pharmaceutical compositions
NZ728442A (en)	2004-10-21	2018-05-25	Adare Pharmaceuticals Inc	Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US20060105038A1 (en) *	2004-11-12	2006-05-18	Eurand Pharmaceuticals Limited	Taste-masked pharmaceutical compositions prepared by coacervation
JP4972311B2 (ja) *	2004-12-15	2012-07-11	あすか製薬株式会社	イソソルビドの苦味が軽減された経口製剤及びその製造方法
JP2012107060A (ja) *	2004-12-15	2012-06-07	Aska Pharmaceutical Co Ltd	イソソルビドの苦味が軽減された経口製剤及びその製造方法
DE102005019458A1 (de)	2005-04-25	2006-10-26	Grünenthal GmbH	Darreichungsform mit verbesserter Freisetzung von Cefuroximaxetil
US9161918B2 (en)	2005-05-02	2015-10-20	Adare Pharmaceuticals, Inc.	Timed, pulsatile release systems
CN100402035C (zh) *	2005-07-07	2008-07-16	石药集团中奇制药技术（石家庄）有限公司	一种微囊化头孢呋辛酯的药物组合物
US8637076B2 (en) *	2006-06-01	2014-01-28	Cima Labs Inc.	Prednisolone salt formulations
US20070281014A1 (en) *	2006-06-01	2007-12-06	Cima Labs, Inc.	Prednisolone salt formulations
CN101756906B (zh) *	2009-11-02	2011-11-16	严洁	盐酸头孢卡品酯颗粒的药物组合物及其制备方法
AU2010325746B2 (en)	2009-12-02	2016-02-25	Adare Pharmaceuticals S.R.L.	Fexofenadine microcapsules and compositions containing them
WO2011085181A1 (fr) *	2010-01-08	2011-07-14	Eurand, Inc.	Composition de topiramate à goût masqué et comprimé à délitement oral l'incluant
EP2566458B1 (fr)	2010-05-04	2015-08-05	Mahmut Bilgic	Formulations pharmaceutiques comprenant du céfuroxime axétil
JP5853461B2 (ja) *	2010-07-30	2016-02-09	大正製薬株式会社	内服液剤
WO2013024373A1 (fr) *	2011-08-12	2013-02-21	Dhanuka Laboratories Ltd.	Composition pharmaceutique comprenant du céfuroxime
CN102440960A (zh) *	2011-09-01	2012-05-09	山东鲁抗医药股份有限公司	一种头孢呋辛酯干混悬剂药物组合物及其制备方法
CA2852912A1 (fr) *	2011-10-31	2013-05-10	Glaxosmithkline Intellectual Property Limited	Formulation de pazopanib
CN108338936A (zh) *	2017-01-23	2018-07-31	刘全忠	敏感皮肤防护露的制备及使用
JP2023146766A (ja) *	2022-03-29	2023-10-12	味の素株式会社	造粒物およびその製造方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1323161A (en) *	1970-02-16	1973-07-11	Wyeth John & Brother Ltd	Penicillin composition
GB1571683A (en) *	1976-02-16	1980-07-16	Glaxo Operations Ltd	Ester derivatives of cefuroxime
CA1094545A (fr) *	1976-02-16	1981-01-27	Michael Gregson	Traduction non-disponible
YU44680B (en) *	1982-07-30	1990-12-31	Glaxo Lab Ltd	Process for obtaining very pure amorphous form of cephuroxim axetile
GB8320520D0 (en) *	1983-07-29	1983-09-01	Glaxo Group Ltd	Chemical process
GB8524001D0 (en) *	1985-09-30	1985-11-06	Glaxo Group Ltd	Pharmaceutical composition
NL193682C (nl) *	1987-05-14	2000-07-04	Glaxo Group Ltd	Beklede cefuroximaxetilsamenstelling.
US4992276A (en) *	1988-12-14	1991-02-12	Warner-Lambert Company	Antiseptic compositions containing hexahydro-5-pyrimidinamine compounds and thymol and methods for preparing same
ES2194863T3 (es) *	1992-11-30	2003-12-01	Kv Pharm Co	Materiales farmaceuticos con enmascarado de sabor.
WO1994025006A1 (fr) *	1993-04-26	1994-11-10	Affinity Biotech, Inc.	Compositions pharmaceutiques masquant le gout et leurs procedes de production
IT1277426B1 (it) *	1995-08-03	1997-11-10	Acs Dobfar Spa	Forma cristallina biodisponibile del cefuroxima axetil
NZ299077A (en) *	1996-07-26	1998-06-26	Apotex Inc	Preparation of amorphous cefuroxime axetil (a cephalosporin derivative) by dissolving crystalline cefuroxim axetil in a highly polar solvent, typically dmso and/or dmf
JP2002511777A (ja) *	1996-10-28	2002-04-16	ゼネラルミルズ，インコーポレイテッド	調放性粒子の埋包およびカプセル化
CA2209868C (fr) *	1997-08-15	2001-08-14	Bernard Charles Sherman	Compositions pharmaceutiques a base de cefuroxime axetil
GB9726781D0 (en) *	1997-12-19	1998-02-18	Glaxo Group Ltd	Pharmaceutical composition
WO1999033445A1 (fr)	1997-12-29	1999-07-08	The Procter & Gamble Company	Composition de comprime
AT413647B (de) *	1998-11-26	2006-04-15	Sandoz Ag	Verwendung eines copolymerisats aus 1-vinyl-2-pyrrolidon und vinylacetat zur herstellung von cefuroximaxetil-hältigen tabletten
BR0011345A (pt) *	1999-06-11	2002-04-23	Ranbaxy Lab Ltd	Composições com sabor mascarado

2002
- 2002-11-20 CZ CZ200213690U patent/CZ12993U1/cs not_active IP Right Cessation
- 2002-11-20 HR HR20020924A patent/HRP20020924A2/hr not_active Application Discontinuation
- 2002-11-20 HR HR20020923A patent/HRP20020923A2/hr not_active Application Discontinuation
- 2002-11-20 ES ES200202670A patent/ES2201932B2/es not_active Expired - Fee Related
- 2002-11-21 PL PL357259A patent/PL205325B1/pl unknown
- 2002-11-21 PT PT02777359T patent/PT1446126E/pt unknown
- 2002-11-21 CA CA002408198A patent/CA2408198C/fr not_active Expired - Lifetime
- 2002-11-21 NZ NZ533092A patent/NZ533092A/en not_active IP Right Cessation
- 2002-11-21 FR FR0214587A patent/FR2832635B1/fr not_active Expired - Fee Related
- 2002-11-21 GR GR20020100506A patent/GR1004522B/el unknown
- 2002-11-21 AU AU2002338950A patent/AU2002338950A1/en not_active Abandoned
- 2002-11-21 JP JP2002337570A patent/JP3497503B2/ja not_active Expired - Fee Related
- 2002-11-21 EP EP02777359A patent/EP1446126B1/fr not_active Expired - Lifetime
- 2002-11-21 DE DE60236952T patent/DE60236952D1/de not_active Expired - Lifetime
- 2002-11-21 HU HU0204026A patent/HUP0204026A3/hu unknown
- 2002-11-21 SI SI200230920T patent/SI1446126T1/sl unknown
- 2002-11-21 DE DE10254412A patent/DE10254412A1/de not_active Withdrawn
- 2002-11-21 AU AU2002302147A patent/AU2002302147B2/en not_active Ceased
- 2002-11-21 AT AT02777359T patent/ATE473006T1/de active
- 2002-11-21 GB GB0227215A patent/GB2383536B/en not_active Expired - Fee Related
- 2002-11-21 BE BE2002/0668A patent/BE1015217A5/fr not_active IP Right Cessation
- 2002-11-21 IT IT002470A patent/ITMI20022470A1/it unknown
- 2002-11-21 KR KR1020047007847A patent/KR100979328B1/ko not_active Expired - Fee Related
- 2002-11-21 CH CH01954/02A patent/CH693982A5/de not_active IP Right Cessation
- 2002-11-21 WO PCT/EP2002/013150 patent/WO2003043638A1/fr not_active Ceased
- 2002-11-21 ZA ZA200209473A patent/ZA200209473B/xx unknown
- 2002-11-21 TR TR2002/02559A patent/TR200202559A2/xx unknown
- 2002-11-21 CN CNB021522375A patent/CN1297274C/zh not_active Expired - Lifetime
- 2002-11-21 DK DK02777359.7T patent/DK1446126T3/da active
- 2002-11-21 DE DE20218068U patent/DE20218068U1/de not_active Expired - Lifetime
- 2002-11-21 MX MXPA02011561A patent/MXPA02011561A/es active IP Right Grant
- 2002-11-21 RU RU2002131380/15A patent/RU2241460C2/ru active
- 2002-11-21 US US10/301,452 patent/US20030161888A1/en not_active Abandoned
- 2002-11-21 BR BR0204767-5A patent/BR0204767A/pt not_active IP Right Cessation
- 2002-11-21 ES ES02777359T patent/ES2347536T3/es not_active Expired - Lifetime
- 2002-11-21 BE BE2002/0667A patent/BE1014078A6/fr not_active IP Right Cessation
- 2002-11-21 IL IL16197202A patent/IL161972A0/xx unknown
2004
- 2004-05-13 IL IL161972A patent/IL161972A/en active IP Right Grant
- 2004-05-18 CO CO04045861A patent/CO5580783A2/es not_active Application Discontinuation
- 2004-06-22 NO NO20042620A patent/NO335273B1/no not_active IP Right Cessation
2010
- 2010-09-13 CY CY20101100828T patent/CY1110778T1/el unknown

Also Published As

Publication number	Publication date
CN1297274C (zh)	2007-01-31
CA2408198A1 (fr)	2003-02-02
PL357259A1 (en)	2003-06-02
NO335273B1 (no)	2014-11-03
CH693982A5 (de)	2004-05-28
HRP20020924A2 (en)	2003-10-31
ES2201932A1 (es)	2004-03-16
HUP0204026A3 (en)	2004-09-28
HU0204026D0 (en)	2003-01-28
AU2002302147B2 (en)	2005-01-20
BR0204767A (pt)	2003-09-16
JP3497503B2 (ja)	2004-02-16
ITMI20022470A1 (it)	2003-05-24
DK1446126T3 (da)	2010-10-11
ES2347536T3 (es)	2010-11-02
DE60236952D1 (de)	2010-08-19
ATE473006T1 (de)	2010-07-15
ZA200209473B (en)	2003-06-10
NZ533092A (en)	2006-02-24
GR1004522B (el)	2004-04-06
PT1446126E (pt)	2010-09-24
RU2241460C2 (ru)	2004-12-10
IL161972A (en)	2009-06-15
US20030161888A1 (en)	2003-08-28
SI1446126T1 (sl)	2010-10-29
HUP0204026A2 (hu)	2003-08-28
GB2383536B (en)	2003-11-19
FR2832635B1 (fr)	2006-04-21
WO2003043638A1 (fr)	2003-05-30
CA2408198C (fr)	2004-03-09
GR20020100506A (el)	2003-07-16
PL205325B1 (pl)	2010-04-30
NO20042620L (no)	2004-06-22
DE20218068U1 (de)	2003-03-27
BE1014078A6 (fr)	2003-03-04
EP1446126B1 (fr)	2010-07-07
DE10254412A1 (de)	2003-06-12
CN1421206A (zh)	2003-06-04
CZ12993U1 (cs)	2003-02-10
CY1110778T1 (el)	2015-06-10
TR200202559A2 (tr)	2003-06-23
ES2201932B2 (es)	2005-03-16
HRP20020923A2 (en)	2003-10-31
CO5580783A2 (es)	2005-11-30
AU2002338950A1 (en)	2003-06-10
GB2383536A (en)	2003-07-02
GB0227215D0 (en)	2002-12-24
KR20050044590A (ko)	2005-05-12
BE1015217A5 (fr)	2004-11-09
MXPA02011561A (es)	2005-07-13
FR2832635A1 (fr)	2003-05-30
KR100979328B1 (ko)	2010-08-31
EP1446126A1 (fr)	2004-08-18
JP2003160493A (ja)	2003-06-03

Publication	Publication Date	Title
IL161972A0 (en)	2005-11-20	Coated particulate cefuroxime axetil compositions
HK106191A (en)	1992-01-03	Pharmaceutical composition
BR9912979B1 (pt)	2010-09-21	composição farmacêutica administrável oralmente, tablete de mascar, cápsula e uso de chitosan.
CA2330061A1 (fr)	1999-11-11	Formule enterale nutritionnelle complete a faible ph
CA2034569A1 (fr)	1991-07-21	Formes pharmaceutiques de pimobendane pour administration par voie orale
CA2336570A1 (fr)	2000-01-20	Croscarmellose comme masquant de saveur
WO1998023262A3 (fr)	1998-09-11	Pastille pour la liberation modifiee de principes actifs dans le tractus gastro-intestinal
WO2002080708A3 (fr)	2004-03-04	Necessaire de fumeurs
RU2002131380A (ru)	2004-06-27	Фармацевтические композиции
WO2002017894A3 (fr)	2002-08-08	Utilisation d'une combinaison de salmeterol et de propionate de fluticasone
WO2003061728A3 (fr)	2003-12-31	Administration par voie orale d'interferons-tau
WO2004009085A3 (fr)	2004-05-13	Comprimes de sumatriptan a gout masque et procedes de fabrication
RU93048335A (ru)	1997-01-10	Оральная лекарственная форма, материал для оболочки
AU1289300A (en)	2000-06-19	Diagnosis of gastric and lung disorders
GEP20063821B (en)	2006-05-10	Orodispersible pharmaceutical composition comprising perindopril
WO1998027832A3 (fr)	1998-08-13	Utilisation d'oligosaccharides pour renforcer le pouvoir edulcorant et ameliorer le gout d'un melange acesulfame-k/aspartame
AU5816298A (en)	1998-08-07	Taste masking for unpalatable formulations
WO1998036732A3 (fr)	1998-10-22	Preparation combinee pour antibiotiques administrables par voie orale
IL162524A0 (en)	2005-11-20	Derivatives of (pyridin-3-yl)-1-azabicycloÄ3.2.1Ü octane, their preparation and their terapeutic application
CA2312072A1 (fr)	2001-03-23	Cereale de grain de riz sauvage souffle sans huile
GEP20063819B (en)	2006-05-10	Orodispersible pharmaceutical composition comprising piribedil
WO2003013471A3 (fr)	2007-11-08	Composition pharmaceutique a enrobage enterique comprenant du chitosane
MX9602863A (es)	1997-09-30	Preparacion farmaceutica en forma de capsula recubierta liberable en la parte inferior del tracto digestivo.
YU42001A (sh)	2003-12-31	Dijetetsko slatko čajno pecivo
RU2000116065A (ru)	2002-06-20	Биологически активная пищевая добавка "почечные"